Abstract
The pharmacist, as the medicines expert, should be able to assess the quality and safety of a biopharmaceutical and needs to know which criteria to use for the evaluation. A checklist incorporates the regulatory requirements and gives guidance when choosing biopharmaceuticals and biosimilars.
| Original language | English |
|---|---|
| Pages (from-to) | 73-76 |
| Number of pages | 4 |
| Journal | EJHP Practice |
| Volume | 14 |
| Issue number | 1 |
| Publication status | Published - 2008 |
Research programs
- EMC OR-01-34-01